Cardiology electrodes are used to monitor the electrical activity and signals of the heart. They help doctors diagnose various heart conditions through electrocardiograms (ECGs) and other cardiology tests. A few common types of electrodes used include surface electrodes, subcutaneous electrodes, and needle electrodes. Surface electrodes are the most widely used as they are non-invasive and easy to apply.
The global cardiology electrodes market is estimated to be valued at US$ 134.71 Mn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market Dynamics:
Rising healthcare spending is one of the major drivers propelling the growth of the Global Cardiology Electrodes Market Size. According to data by the World Bank, global current health expenditure as a percentage of GDP increased from 9.88% in 2015 to 10.02% in 2020. Governments across countries are increasingly allocating higher budgets towards improving public healthcare infrastructure and services. This is enabling better access to cardiology treatments and diagnosis through technologies like ECG and stress testing that utilize electrodes. The increasing geriatric population is also fueling the need for cardiology care. As per UN data, the population aged 65 years and above is projected to grow from 703 million in 2019 to 1.5 billion in 2050. Older adults are more prone to cardiovascular diseases, thereby driving demand for cardiology electrodes.
SWOT Analysis
Strength: Cardiology electrodes have wide applications in various cardiology procedures like ECG, EEG, EMG etc. They provide clear signals and are affordable. Cardiology electrodes have reliable connectivity and skin adhesion. They minimize noise and interference for accurate diagnosis.
Weakness: Some patients have sensitive skin which can cause skin irritation from long term use of electrodes. Adhesives used in electrodes can cause allergic reactions in some individuals. Durability of electrodes is limited as adhesives lose stickiness with time.
Opportunity: Growth of geriatric population prone to cardiovascular diseases increases demand for cardiology procedures. This drives the need for quality and affordable electrodes. Advancements in material sciences can enhance electrode durability, connectivity and skin compatibility. Emerging economies provide lucrative growth opportunities.
Threats: Presence of local manufacturers offering low cost alternatives. Stringent regulatory approvals for new products delay market entry. Replacement of some procedures by advanced non-invasive diagnostics poses threat.
Key Takeaways
The global Cardiology Electrodes market is expected to witness high growth. Growing prevalence of cardiovascular diseases, rise in geriatric population and expanding healthcare infrastructure across developing nations will boost the market in the forecast period. The global cardiology electrodes market is estimated to be valued at US$ 134.71 Mn in 2023 and is expected to exhibit a CAGR of 5.3% over the forecast period 2023 to 2030.
North America dominates currently due to advanced healthcare systems and high acceptance of new technologies. However, Asia Pacific is expected to witness highest growth owing to growing medical tourism, rising healthcare spending and large patient pool. Countries like China, India provide huge untapped opportunities.
Key players operating in the Cardiology Electrodes market are Leonhard Lang, Nissha Medical Technologies, Conmed Corporation, Koninklijke Philips N.V., GE Healthcare (General Electric Company), Medtronic plc, BPL Medical Technologies, FARUM sp. z o.o., INTCOMEDICAL.COM., Promed Technology Co., Ltd., 3M, VectraCor, Medico Electrodes International Ltd., Ambu A/S., and Cardinal Health.
Get More Insights On This Topic: https://www.trendingwebwire.com/cardiology-electrodes-market-analysis-growth-forecast-outlook-2023-2030/